DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, giving promising advancements throughout many health-related and industrial programs. With its structural similarity to In a natural way derived human serum albumin, OsrHSA supplies a safer, additional reliable option for therapeutic use,